TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in TScan Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +12 vs. Q4 2023
- Shares held
- 34.3M
- +2.38M (+7.5%) vs. Q4 2023
- Total value
- $272.3M
- +$86.3M (+46.4%) vs. Q4 2023
- New holders
- 17
- 22 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 1,618 | $13 | 0.00% | +1,618 | New |
| Atlas Capital Advisors LLC | 18 | $142 | 0.00% | −878−98.0% | Reduced |
| Federated Hermes, Inc. | 56 | $445 | 0.00% | +56 | New |
| Wells Fargo & Company | 306 | $2.43K | 0.00% | +5+1.7% | Added |
| UBS Group AG | 1,901 | $15.1K | 0.00% | +477+33.5% | Added |
| Lazard Asset Management LLC | 2,551 | $19.0K | 0.00% | −1,432−36.0% | Reduced |
| Waldron Private Wealth LLC | 10,000 | $79.4K | 0.00% | 00.0% | Unchanged |
| Aries Wealth Management | 10,000 | $79.4K | 0.03% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 10,061 | $80.0K | 0.00% | +10,061 | New |
| Jump Financial, LLC | 10,291 | $81.7K | 0.00% | +10,291 | New |
| CTC Alternative Strategies, Ltd. | 11,000 | $87.3K | 0.05% | +11,000 | New |
| Citadel Advisors LLC | 11,432 | $90.8K | 0.00% | +11,432 | New |
| Jefferies Financial Group Inc. | 12,200 | $96.9K | 0.00% | +12,200 | New |
| Omers Administration Corp | 14,200 | $112.7K | 0.00% | +14,200 | New |
| Privium Fund Management (UK) Ltd | 15,825 | $126.8K | 0.06% | 00.0% | Unchanged |
| Credit Suisse AG | 17,366 | $137.9K | 0.00% | +17,366 | New |
| Cannon Global Investment Management, LLC | 17,500 | $138.9K | 0.37% | +17,500 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 19,736 | $156.7K | 0.04% | +19,736 | New |
| Letko, Brosseau & Associates Inc | 20,700 | $164.4K | 0.00% | 00.0% | Unchanged |
| Pale Fire Capital SE | 21,573 | $171.3K | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 22,104 | $175.5K | 0.00% | 00.0% | Unchanged |
| Y-Intercept (Hong Kong) Ltd | 24,446 | $194.1K | 0.01% | +9,441+62.9% | Added |
| Bank of America Corp | 30,179 | $239.6K | 0.00% | −7,625−20.2% | Reduced |
| American Century Companies Inc | 31,885 | $253.2K | 0.00% | +10,570+49.6% | Added |
| Brevan Howard Capital Management LP | 34,578 | $274.5K | 0.02% | +34,578 | New |
| HRT Financial LP | 34,789 | $276.0K | 0.00% | +34,789 | New |
| DC Investments Management, LLC | 35,563 | $282.4K | 0.24% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 35,661 | $283.0K | 0.00% | −28,117−44.1% | Reduced |
| Two Sigma Investments, LP | 37,747 | $299.7K | 0.00% | +37,747 | New |
| Balyasny Asset Management LLC | 41,942 | $333.0K | 0.00% | −4,044−8.8% | Reduced |
| Cubist Systematic Strategies, LLC | 44,308 | $351.8K | 0.00% | +18,063+68.8% | Added |
| Renaissance Technologies LLC | 47,000 | $373.0K | 0.00% | +25,300+116.6% | Added |
| Marathon Trading Investment Management LLC | 51,000 | $404.9K | 0.16% | +51,000 | New |
| Walleye Capital LLC | 52,478 | $416.7K | 0.00% | +34,701+195.2% | Added |
| Bridgeway Capital Management, LLC | 63,300 | $502.6K | 0.01% | −25,000−28.3% | Reduced |
| JPMorgan Chase & Co | 67,013 | $532.1K | 0.00% | +33,783+101.7% | Added |
| Northern Trust Corp | 76,960 | $611.1K | 0.00% | +5,349+7.5% | Added |
| Man Group plc | 77,339 | $614.1K | 0.00% | +26,929+53.4% | Added |
| NewEdge Wealth, LLC | 91,463 | $791.2K | 0.02% | 00.0% | Unchanged |
| Stifel Financial Corp | 101,400 | $805.1K | 0.00% | −19,000−15.8% | Reduced |
| Citigroup Inc | 116,921 | $928.4K | 0.00% | +43,758+59.8% | Added |
| State Street Corp | 135,000 | $1.07M | 0.00% | +73,900+120.9% | Added |
| Qube Research & Technologies Ltd | 143,536 | $1.14M | 0.00% | +63,547+79.4% | Added |
| Jane Street Group, LLC | 153,133 | $1.22M | 0.00% | +69,511+83.1% | Added |
| Marshall Wace, LLP | 191,171 | $1.52M | 0.00% | +80,620+72.9% | Added |
| Standard Life Aberdeen plc | 200,000 | $1.59M | 0.00% | 00.0% | Unchanged |
| Tocqueville Asset Management L.P. | 212,200 | $1.68M | 0.03% | +212,200 | New |
| Morgan Stanley | 223,894 | $1.78M | 0.00% | −10,809−4.6% | Reduced |
| Goldman Sachs Group Inc | 260,148 | $2.07M | 0.00% | +229,863+759.0% | Added |
| Susquehanna International Group, LLP | 297,902 | $2.37M | 0.00% | +193,954+186.6% | Added |
| Laurion Capital Management LP | 362,484 | $2.88M | 0.08% | +302,084+500.1% | Added |
| Millennium Management LLC | 392,115 | $3.11M | 0.00% | +293,033+295.7% | Added |
| Geode Capital Management, LLC | 413,779 | $3.29M | 0.00% | +22,133+5.7% | Added |
| Invesco Ltd. | 488,415 | $3.88M | 0.00% | +488,415 | New |
| DC Funds, LP | 630,000 | $5.00M | 48.34% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $8.31M | 0.80% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $8.55M | 0.34% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,504 | $9.89M | 1.79% | −10.0% | Reduced |
| BlackRock Inc. | 1,699,213 | $13.5M | 0.00% | +27,486+1.6% | Added |
| Vanguard Group Inc | 1,808,152 | $14.4M | 0.00% | +20,000+1.1% | Added |
| Propel Bio Management, LLC | 2,087,139 | $16.6M | 9.65% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,784,792 | $22.1M | 0.28% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $23.7M | 0.65% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,900,000 | $31.0M | 0.06% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,000,000 | $39.7M | 1.01% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 5,224,600 | $41.5M | 10.68% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −43,198−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,418−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,670−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −13,293−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −43−100.0% | Sold out |